Zavabresib is an investigational new drug that is being evaluated by Plexxikon/Opna Bio for the treatment of myelofibrosis. It is a BRD4 protein inhibitor.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.